Skip to main content
Clinical Trials/ACTRN12623000672651
ACTRN12623000672651
Recruiting
未知

e-PINO: early Prediction of Infant Neurodevelopmental Outcomes using novel biomarkers

niversity of Queensland0 sites660 target enrollmentJune 21, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Brain development in preterm infants
Sponsor
niversity of Queensland
Enrollment
660
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Queensland

Eligibility Criteria

Inclusion Criteria

  • Infant’s admitted to the Neonatal Intensive Care Units at the (i) Royal Brisbane and Women’s Hospital (ii) Monash Children’s Hospital (iii) Westmead Hospital and Westmead Children’s Hospital will be invited to participate if they meet the following inclusion criteria (1\) six groups neonates (n\=540\) Preterm\-born with any birth weight (BW), very preterm (VPT) less than 32 weeks,
  • (ii) Moderate to Late Preterm MLPT (Born 32\-37 weeks)
  • (iii) near\-term small for gestational age (SGA) (BW less than 10th percentile) or with Fetal Growth Restriction (FGR);
  • (iv) Term born with Hypoxic ischemic encephalopathy (HIE) and/or stroke;
  • (v) Healthy Term (HT); (2\) no known chromosomal abnormalities; (3\) inborn at Royal Brisbane/Monash/Westmead Hospitals; (4\) live within 200 km; (5\) English spoken.

Exclusion Criteria

  • Have a congenital or chromosomal abnormality that would impact their development

Outcomes

Primary Outcomes

Not specified

Similar Trials